Compare GAME & ZTEK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GAME | ZTEK |
|---|---|---|
| Founded | 2011 | 2008 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | | Major Chemicals |
| Sector | | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 43.4M | 51.8M |
| IPO Year | 2024 | 2022 |
| Metric | GAME | ZTEK |
|---|---|---|
| Price | $0.39 | $0.46 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 849.5K | 263.8K |
| Earning Date | 04-08-2026 | 02-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 65.14 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $44,999,302.00 | N/A |
| Revenue This Year | $87.12 | N/A |
| Revenue Next Year | $21.14 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.24 | $0.37 |
| 52 Week High | $1.44 | $1.24 |
| Indicator | GAME | ZTEK |
|---|---|---|
| Relative Strength Index (RSI) | 52.96 | 46.46 |
| Support Level | $0.37 | $0.38 |
| Resistance Level | $0.48 | $0.56 |
| Average True Range (ATR) | 0.03 | 0.04 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 81.72 | 19.74 |
GameSquare Holdings Inc is a vertically integrated digital media, entertainment, and technology company focused on gaming and youth culture audiences. The company operates through four reportable segments: Owned and Operated IP, Agency, SaaS and managed services, and Yield. It provides services including influencer marketing, esports talent management, creative production, merchandise and consumer products, live streaming analytics, and digital media solutions through its various brands and platforms. It generates the majority of its revenue from the Agency segment.
Zentek Ltd is an IP development and commercialization company focused on next-gen healthcare solutions in the areas of prevention, detection, and treatment. It is focused on commercializing ZENGuard, a patent-pending coating with 99% antimicrobial activity, including against COVID-19, and the potential to use similar compounds as pharmaceutical products against infectious diseases.